OpenAlex
PricingAboutJobs
Log inGet started
Work

Minimizing DILI risk in drug discovery — A screening tool for drug candidates

HTML

Year: 2015
Type: article
Source: Toxicology in Vitro
DOI: 10.1016/j.tiv.2015.09.019
Authors: S. Schadt, S. Simon, S. Kustermann, F. Boess, C. McGinnis, A. Brink, R. Lieven, S. Fowler, K. Youdim, M. Ullah, M. Marschmann, C. Zihlmann, Y.M. Siegrist, A.C. Cascais, E. Di Lenarda, E. Durr, N. Schaub, X. Ang, V. Starke, T. Singer, R. Alvarez-Sanchez, A.B. Roth, F. Schuler, C. Funk
Institution: F. Hoffmann-La Roche AG
Language: English

Topic: Drug-Induced Hepatotoxicity and Protection
Subfield: Pharmacology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: drug-induced liver injury, drug safety assessment, drug candidates, CYP3A4 inhibition, glutathione adducts, mitochondrial toxicity, hepatocyte cytotoxicity, fibroblast cytotoxicity, dose calibration, drug withdrawal
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1790779685
FWCI: 7.952
Cites: 31
Cited by: 97
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security